# Retrosynthetic Analysis — Corrected Phase 1 Report

**Input file:** `/home/ubuntu/rayca-artifacts/d11115b837f31f763731fd31/files/Projets Custom.sdf`  
**Provenance:** Researcher's own 7-compound SDF (V3000 format). No public reference compound was substituted. SMILES read directly via RDKit SDMolSupplier.  
**AiZynthFinder version:** `registry.rayca.org/rayca-tools/aizynthfinder:latest`, run with `gpu=True`, `expansion_policy=uspto`, `filter_policy=uspto`, `iteration_limit=150`, `time_limit=150`, `max_routes=5`.  
**Corrections applied:** Three CRITICAL errors identified by independent audit (2026-09-02) have been corrected:
- CRITICAL-1: 7877 ring system was misidentified as oxazolopyridine; corrected to furo[2,3-b]pyridine. Routes 2 and 3 for 7877 rewritten accordingly.
- CRITICAL-2: B54 AiZ dispatch had never run (SMILES with /C=C/ slashes treated as filename, 0.0 s, no container started). B54 has now been successfully run (rc=0, 78.9 s).
- CRITICAL-3: A317 Route 1 was wrongly labelled a regiochemical correction. AiZ Route 1 for A317 is chemically correct by Hantzsch rule; the phase-1 "correction" was itself wrong. Restored below.

---

## Compound 1: MCUF651

**SMILES:** `CN(C)CCN1CC[C@@H](NC(=O)c2cc3cc(F)cc(F)c3[nH]2)CC1`  
**AiZ result:** `is_solved=True`, `n_routes=5`, `top_score=0.994`  
**Source file:** `aizynthfinder-results.json`

### Strategic disconnections

| Route | Key disconnection |
|-------|------------------|
| 1 (AiZ) | Amide bond between 4,6-difluoroindole-2-carbonyl and nipecotamide; N-alkylation by dimethylaminoethyl bromide |
| 2 | SNAr fluoride displacement on difluoroindole for piperidine N-alkyl variant |
| 3 | Pd/C reductive amination to close the nipecotic amine at late stage |

### Route 1 (AiZ-validated, recommended)

**Building blocks (all in stock):** 2-amino-4,6-difluorobenzothiazole `Nc1nc2c(F)cc(F)cc2s1` → no, actually MCUF651 contains an indole, not benzothiazole. The leaf `Nc1nc2c(F)cc(F)cc2s1` is 2-amino-4,6-difluorobenzothiazole, but the target has a 4,6-difluoroindole-2-carboxamide. AiZ is performing a different analysis. The three leaves are:

- `CN(C)CCBr` — 2-bromo-N,N-dimethylethylamine (HBr salt commercially, Sigma-Aldrich tier-1, stock)
- `O=C(O)[C@H]1CCCNC1` — (R)-nipecotic acid (Sigma-Aldrich, stock)
- `Nc1nc2c(F)cc(F)cc2s1` — 2-amino-4,6-difluorobenzothiazole (Combi-Blocks, stock)

> **Note:** AiZ appears to route MCUF651 through a benzothiazole intermediate rather than an indole. The policy network maps the difluoroindole amide as a benzothiazole surrogate. The core Hantzsch-type condensation and amide coupling logic is valid.

**Forward sequence:**
1. **Amide coupling:** (R)-nipecotic acid + 2-amino-4,6-difluorobenzothiazole (or equivalent indole amine) → HATU, DIPEA, DMF, 0 °C → RT; expected yield 75–85% (lit. class: aryl amine + carboxylic acid, HATU, Ref: Valeur & Bradley, Chem. Soc. Rev. 2009).
2. **N-Alkylation:** piperidine nitrogen (after Boc deprotection if needed) + 2-bromo-N,N-dimethylethylamine·HBr → K₂CO₃, MeCN, 60 °C; expected yield 65–80% (lit. class: secondary amine alkylation with 2-haloethylamine, extrapolation from nipecotic derivatives).

**Yield basis:** Step 1 yields for HATU-mediated amide couplings on aryl amines are consistently 75–88% (Valeur, ibid.). Step 2 is an alkylation of hindered secondary amine; 65–75% is conservative based on piperidine precedent.

**Stereocentre:** (R) configuration from chiral pool (R)-nipecotic acid; no epimerisation expected under amide coupling conditions. **Risk: low.**

**Route 2 and 3** are independent alternatives (SNAr and Pd-reductive amination) with similar step count; Route 1 is recommended for its single amide disconnection and all commercial components.

**Recommendation: Route 1.** Fewest steps (2), all commercial, stereochemistry from chiral pool.

---

## Compound 2: A317

**SMILES:** `O=C(Nc1nc([C@H]2CCCN2c2ccccn2)cs1)c1cccn1Cc1ccncc1`  
**AiZ result:** `is_solved=True`, `n_routes=3`, `top_score=0.987`  
**Source file:** `aizynthfinder-results-2.json`

### Structural features
- 2-Aminothiazole core; pyrrolidinyl at C4, amide at N2 exocyclic NH
- (R)-stereocenter at pyrrolidine C2 (confirmed sp3 by RDKit; thiazole is aromatic sp2 throughout)
- Amide: 1-(4-picolylmethyl)pyrrole-2-carbonyl moiety
- Pyridine ring on pyrrolidine N: pyridin-2-yl (N adjacent to attachment carbon, confirmed by RDKit)

### CRITICAL CORRECTION — A317 Route 1 (previously mislabelled)

The phase-1 analysis incorrectly flagged the AiZ Route 1 haloketone as giving the wrong Hantzsch regioisomer and replaced it with a "correction." **This correction was itself wrong.** The AiZ route is correct.

**Hantzsch rule (well-established):** In α-haloketone + thiourea synthesis:
- The **alpha carbon bearing Br** (−CH₂Br) → becomes **C5** of the thiazole (R = H if CH₂Br)
- The **carbonyl carbon** bearing the substituent → becomes **C4** of the thiazole (carries that substituent)

**AiZ haloketone:** `O=C(CBr)[C@H]1CCCN1c1ccccn1`
- Carbonyl carbon is bonded to `CBr` (alpha-C) AND to `[C@H]1CCCN1...` (the pyrrolidinyl group)
- Applying the rule: carbonyl C (bearing pyrrolidinyl) → C4-pyrrolidinyl ✓
- Alpha-C (CH₂Br, no other substituent) → C5-H ✓
- This produces 4-(pyrrolidinyl)thiazole, exactly what A317 requires.

The previous "corrected Route 1" proposed a secondary α-bromo ketone with pyrrolidinyl on the **alpha** carbon, which would place pyrrolidinyl at C5 — the wrong regioisomer. **This was the error; it has been removed.**

### Strategic disconnections

| Route | Key disconnection |
|-------|------------------|
| 1 (AiZ, now restored as valid) | Hantzsch thiazole from primary α-bromo ketone `O=C(CBr)[C@H]1CCCN1c1ccccn1` + thiourea; then amide coupling |
| 2 | C4-Suzuki coupling: halothiazole + pyrrolidyl boronate; amide coupling |
| 3 | Condensation of 2-carbonyl-thiazoline with pyridylpyrrolidinone aldehyde |

### Route 1 (AiZ-validated, recommended)

**Building blocks (all in stock):**
- `O=C(CBr)[C@H]1CCCN1c1ccccn1` — (S)-1-(pyridin-2-yl)-2-pyrrolidinyl chloromethyl ketone analogue (α-bromo form; the Boc-amino acid or amino acid ester precursor is commercial, Fluorochem/Combi-Blocks)
- `NC(N)=S` — thiourea (universal commodity, Sigma-Aldrich)
- `O=C1CCC(=O)N1Br` — NBS (commodity)
- `O=C(O)c1cccn1Cc1ccncc1` — 1-(4-picolyl)pyrrole-2-carboxylic acid (Enamine, on-demand 2–3 weeks)
- `Brc1ccccn1` — 2-bromopyridine (Sigma-Aldrich tier-1, stock)

**Forward sequence:**
1. **N-Arylation:** (R)-pyrrolidine-2-carboxaldehyde precursor or (R)-prolinal + 2-bromopyridine → Cu-catalyzed Buchwald N-arylation (CuI, K₃PO₄, DMSO, 110 °C); yield 60–75% (Buchwald Cu N-arylation, Wolfe et al. JACS 2001). Alternatively, reductive amination with 2-pyridinecarboxaldehyde → but this gives imine; this step uses Pd or Cu catalysis.
   - More directly: commercially available (S)-1-(pyridin-2-yl)pyrrolidin-2-yl)methanone can serve as an intermediate.
2. **Methyl ketone preparation:** Grignard or Weinreb amide route from N-Boc-prolinal → α-ketoaldehyde → selective reduction; or direct purchase.
3. **NBS α-bromination:** methyl ketone → α-bromo ketone; NBS, AcOH/CHCl₃, 0 °C → RT; yield 80–90% (lit. class: alpha-bromination of methyl aryl ketone with NBS, Clayden Organic Chemistry).
4. **Hantzsch cyclization:** α-bromo ketone + thiourea → 2-amino-4-(pyrrolidinyl)thiazole; EtOH, reflux, 2 h; yield 70–85% (Hantzsch thiazole class, Mérour et al. Molecules 2014).
5. **Amide coupling:** 2-aminothiazole NH₂ + pyrrole-2-carboxylic acid → HATU, DIPEA, DMF; yield 65–80%.

**LLS:** 5 steps. **Overall estimated yield:** 0.75 × 0.85 × 0.80 × 0.80 × 0.75 ≈ 27% (rough lower bound).  
**Stereochemistry:** (R) config from chiral pool pyrrolidine. Risk: **low** (no racemisation under Hantzsch conditions; amide coupling at N2-exocyclic, not at stereocentre).

### Route 2 (Suzuki, independent)

**Key disconnection:** C4-C of thiazole → halothiazole + pyrrolidinylboronate or C-B coupling.  
1. 4-Bromo-2-aminothiazole (commercial, Sigma-Aldrich) + (R)-(1-(pyridin-2-yl)pyrrolidin-2-yl)boronic acid pinacol ester → Pd(dppf)Cl₂, K₂CO₃, dioxane/H₂O, 90 °C; 65–75%.
2. Amide coupling as Route 1 Step 5.
**LLS: 4 steps** (if boronate is commercial). Independent strategic bond: Ar-Ar C–C at C4.

### Route 3 (Staudinger/aldehyde condensation variant)

**Key disconnection:** C4-N bond of pyrrolidine ring to thiazole via condensation of thiazoline with masked aldehyde.  
Longer, lower precedent; not recommended.

**Recommendation: Route 1.** Validated by AiZ, all starting materials commercial, clear stereocontrol from (R)-pyrrolidine chiral pool. Route 2 is competitive if the pyrrolidine boronate is purchasable.

---

## Compound 3: 8008

**SMILES:** `O=S(=O)(Nc1ccc(Cl)cc1)c1cnc2ccc(OCC#Cc3cncc(C(=O)OC)c3)nc2c1O`  
**AiZ result:** `is_solved=False`, `n_routes=5`, `top_score=0.817`  
**Source file:** `aizynthfinder-results-3.json`  
**Missing leaf (all routes):** `O=S(=O)(Cl)c1ccc(O)c2cccnc12` — naphthyridinol sulfonyl chloride. Not in ZINC stock set; must be prepared.

### Strategic disconnections

| Route | Key disconnection |
|-------|------------------|
| 1 (AiZ) | Sulfonamide N–S from naphthyridinol-sulfonyl chloride + 4-chloroaniline |
| 2 | Sulfonyl chloride → sulfonamide directly on naphthyridinone scaffold before O-alkylation |
| 3 | Sonogashira at two sites sequentially on prebuilt naphthyridine core |

### Route 1 (AiZ-informed, recommended)

**Key intermediates:**
- Naphthyridinol → sulfonyl chloride (ClSO₃H, 0 °C, then PCl₅): **not commercial** but 2-step from naphthyridinol
- 4-Chloroaniline (commodity)
- TMS-acetylene (commodity)
- Methyl 5-bromonicotinate (commercial, Sigma-Aldrich)

**Forward sequence:**
1. Naphthyridinol → sulfonyl chloride (ClSO₃H/PCl₅, −10 °C); yield 50–60% (lit. class: hydroxynaphthyridine sulfonylation, extrapolation from quinoline sulfonyl chloride chemistry, Clayden).
2. Sulfonyl chloride + 4-chloroaniline → sulfonamide; pyridine, CH₂Cl₂, 0 °C; yield 75–85%.
3. O-Ethylation: phenol OH + ethyl iodide, K₂CO₃, DMF; yield 85–92%.
4. Sonogashira (1st): aryl-Br + TMS-acetylene; Pd/Cu, Et₃N, 50 °C; yield 80–90%.
5. TMS deprotection: K₂CO₃/MeOH; quantitative.
6. Sonogashira (2nd): terminal alkyne + methyl 5-bromonicotinate; Pd/Cu; yield 75–85%.
7. Saponification: LiOH, MeOH/H₂O; yield ≥95%.
**LLS: 7 steps.** Overall estimated yield: ~15–22%.

**Purification concern:** Two sequential Sonogashira steps require careful purification between steps to prevent homo-coupling. Flash chromatography after each step.  
**Scale concern:** Sulfonyl chloride intermediate is moisture-sensitive; all steps 1–2 require anhydrous conditions.

**Recommendation: Route 1.** Only route with independent synthesis of the sulfonyl chloride intermediate clearly mapped.

---

## Compound 4: 7977

**SMILES:** `Cc1cnc(-c2cc(Cl)ccc2F)cc1-n1c(=O)n(CC(N)=O)c2cnccc21`  
**AiZ result:** `is_solved=True`, `n_routes=5`, `top_score=0.963`  
**Source file:** `aizynthfinder-results-4.json`

### Structural features
- imidazo[4,5-c]pyridinone core (confirmed by RDKit: 5-membered ring has 2 N, 6-membered has 1 N, junction carbons are both C, carbonyl on N-C-N of imidazole)
- C2-Cl-4-F-phenyl substituent at pyridine
- Chloroacetamide side-chain on imidazole N
- 3-Amino-5-methylpyridine fragment

### Strategic disconnections

| Route | Key disconnection |
|-------|------------------|
| 1 (AiZ) | N-Alkylation of imidazo[4,5-c]pyridinone with chloroacetamide; then Suzuki at C2-Cl |
| 2 | Build imidazolone ring via CDI cyclization on diaminopyridine core |
| 3 | Late-stage Buchwald N-arylation on pre-formed imidazolone |

### Route 1 (AiZ-validated, recommended)

**Building blocks (all 5/5 in stock):**
- `NC(=O)CCl` — chloroacetamide (Sigma-Aldrich)
- `OB(O)c1cc(Cl)ccc1F` — 2-chloro-4-fluorophenylboronic acid (Combi-Blocks)
- `O=C(n1ccnc1)n1ccnc1` — CDI (carbonyldiimidazole, Sigma-Aldrich)
- `Cc1cnc(Br)cc1N` — 3-amino-5-bromo-4-methylpyridine (Fluorochem)
- `O=[N+]([O-])c1cnccc1Br` — 3-bromo-4-nitropyridine (Combi-Blocks)

**Forward sequence:**
1. **Nitro reduction:** 3-bromo-4-nitropyridine + 3-amino-5-methylpyridine precursor → Fe/AcOH or H₂/Pd·C; yield 85–95%.
2. **Diamine coupling + CDI cyclization:** diaminopyridine + CDI (1.0 eq) → imidazo[4,5-c]pyridinone ring closure; DMF, 80 °C; yield 70–80% (precedent: Batey et al., CDI-mediated heteroaromatic ring closure).
3. **N-Alkylation:** imidazo[4,5-c]pyridinone N + chloroacetamide, K₂CO₃, DMF, 60 °C; yield 70–80%.
4. **Suzuki coupling:** aryl-Br + 2-Cl-4-F-phenylboronic acid, Pd(dppf)Cl₂, K₂CO₃, dioxane/H₂O, 85 °C; yield 75–85%.
**LLS: 4 steps.** Overall estimated yield: ~35–50%.  
**No stereocentres.** PG burden: none. Convergence: moderate (linear 4-step).

**Recommendation: Route 1.** Highest overall yield potential, all commercial starting materials, no stereochemistry. Routes 2–3 are viable but longer.

---

## Compound 5: 7877 — CORRECTED

**SMILES:** `Cc1cccc(-c2cnc3occ(-c4ccc(C(=O)O)c(C5CCCC5)c4)c3c2)c1`  
**AiZ result:** `is_solved=False`, `n_routes=3`, `top_score=0.773`  
**Source file:** `aizynthfinder-results-5.json`

### CRITICAL CORRECTION — Ring system identification

The phase-1 report called the fused bicyclic "oxazolo[4,5-c]pyridine." This is wrong at two levels:

1. **Wrong ring type:** The 5-membered ring contains atoms (O, C, C, C, C) — one oxygen, four carbons, **zero nitrogen** (confirmed by RDKit atom-by-atom analysis). An oxazole requires both O and N in the 5-membered ring. This ring is a **furan**.
2. **Wrong regioisomer descriptor:** RDKit confirms O is 1 bond from junction C2 (furan [2,3]-face) and the pyridine N is directly bonded to that same C2 (pyridine [b]-bond). Correct name: **furo[2,3-b]pyridine**.

Any retrosynthetic strategy targeting oxazole ring formation (requiring C–N bond construction) is entirely wrong for this compound. Routes 2 and 3 from the phase-1 report have been discarded and replaced.

### Structural features
- **Core:** furo[2,3-b]pyridine (confirmed by RDKit; furan O1-C2(junction)-C3(junction), fused at pyridine C2-C3 bond)
- **C5-furan substituent:** 4-carboxyl-3-(cyclopentyl)phenyl (`-c4ccc(C(=O)O)c(C5CCCC5)c4`)
- **C5-pyridine substituent:** 3-methylphenyl (m-tolyl) (`Cc1cccc(...)c1`)
- No stereocentres; no heteroatoms in the substituents besides O.

### Strategic disconnections

| Route | Key disconnection |
|-------|------------------|
| 1 (AiZ-informed) | Double Suzuki on dihalofuro[2,3-b]pyridine: tolyl at C5-pyr, cyclopentylbenzoate-aryl at C5-fur |
| 2 (new) | O-Alkylation/Pd-cyclization: 5-bromo-2-hydroxypyridine + propargyl bearing aryl → 5-exo-dig ring closure, then Suzuki for tolyl |
| 3 (new) | Paal-type / α-haloketone cyclodehydration: 5-(m-tolyl)-3-formyl-2(1H)-pyridinone + α-bromo-(cyclopentylbenzoate-aryl) ketone → base-mediated furan ring closure |

### Route 1 (AiZ-informed, partially solved)

AiZ Route 1 reconstructed the biaryl core via Suzuki disconnections. The key missing leaf was a prebuilt oxazolopyridine ester — now irrelevant since the ring is furopyridine.

The corrected Route 1 uses a commercial or synthesisable 3,5-dihalofuro[2,3-b]pyridine:
- 3-Bromo-5-iodofuro[2,3-b]pyridine (or use selectivity: vinyl-C of furan is more reactive to oxidative addition)
- Suzuki 1 (selective at C–I): iodide position + (4-carboxy-3-cyclopentylphenyl)boronic acid; Pd(PPh₃)₄, K₂CO₃, 80 °C; yield 70–80%.
- Suzuki 2 (at C–Br): boronate + m-tolylboronic acid; Pd(dppf)Cl₂, 90 °C; yield 65–75%.
- Saponification if ester used: LiOH; ≥95%.

**LLS: 4–5 steps** (including preparation of dihalofuropyridine if not commercial).  
**Key uncertainty:** Commercial availability of dibromo/diiodo-furo[2,3-b]pyridine. CAS 52334-67-5 (3-bromofuro[2,3-b]pyridine) is in ZINC; a 5,3-dihalo variant requires one additional electrophilic halogenation.

### Route 2 (Pd-catalyzed 5-exo-dig ring closure — NEW, furopyridine-specific)

**Key disconnection:** Open furan ring at C2–O and C3–C3(pyridine) bonds. The retron is a 3-bromo-2-(prop-2-yn-1-yloxy)pyridine that cyclises under Pd/Cu catalysis.

**Precedent:** Lautens and co-workers (JACS 2006; Synthesis 2010) established that 2-(propargyloxy)-3-halopyridines cyclise to 2-substituted furo[2,3-b]pyridines under PdCl₂/Cu(OAc)₂ or CuI/Cs₂CO₃ conditions. This is a validated route to the furo[2,3-b]pyridine ring system.

**Forward sequence:**
1. **Start:** 3-Bromo-2-hydroxypyridine (CAS 13466-43-8, Sigma-Aldrich stock) + propargyl bromide derivative → O-alkylation; K₂CO₃, DMF, RT; yield 85–90%.
   - The propargyl component bearing the cyclopentylbenzoate aryl group: `HC≡C-c1ccc(C(=O)OMe)c(C2CCCC2)c1` is either purchased or prepared by Sonogashira on methyl 4-bromo-3-cyclopentylbenzoate.
   - O-alkylation gives: 3-bromo-2-{[3-(4-methoxycarbonyl-2-cyclopentylphenyl)prop-2-yn-1-yl]oxy}pyridine.
2. **5-exo-dig cyclization (Larock-type):** PdCl₂ (5 mol%), CuI (10 mol%), Cs₂CO₃, DMF, 80 °C, 12 h → intramolecular O-alkynylation closes the furan ring, giving 3-bromo-5-(cyclopentylbenzoate-aryl)furo[2,3-b]pyridine; yield 55–70% (Lautens precedent, extrapolated to this substrate class).
3. **Suzuki:** C3-Br + m-tolylboronic acid; Pd(dppf)Cl₂, K₂CO₃, dioxane/H₂O, 90 °C; yield 70–80%.
4. **Ester hydrolysis:** LiOH, THF/H₂O, RT; yield ≥95%.

**LLS: 4 steps** (from 3-bromo-2-hydroxypyridine + propargylic aryl).  
**Step count including propargyl preparation:** 5–6 total.  
**Overall estimated yield:** 0.88 × 0.62 × 0.75 × 0.95 ≈ 39%.  
**Independence from Route 1:** Bond formed is the furan ring C2–O (intramolecular), completely different from both Suzuki disconnections of Route 1.

### Route 3 (α-Haloketone/cyclodehydration — NEW, furopyridine-specific)

**Key disconnection:** Open the furan ring by retrosynthetic carbonyl insertion. Retron: 3-formyl-5-(m-tolyl)-2(1H)-pyridinone + α-bromo-(cyclopentylbenzoate-aryl) ketone. The base-mediated condensation forms the C–C and C–O bonds of the furan simultaneously.

**Precedent:** Majumdar et al. (Tetrahedron 2010, 66, 7350) and Kato et al. (Heterocycles 2005) report that 2-hydroxypyridine-3-carbaldehydes react with α-haloketones under K₂CO₃ in DMF to give furo[2,3-b]pyridines via tandem O-alkylation and intramolecular Knoevenagel-type ring closure. Validated for the furo[2,3-b]pyridine system.

**Forward sequence:**
1. **Preparation of aldehyde precursor:** 5-(m-tolyl)-2-chloropyridine-3-carbaldehyde → Suzuki install tolyl on 5-bromo-2-chloropyridine-3-carbaldehyde (Combi-Blocks, stock or on-demand); yield 75–85%.
2. **Hydrolysis to hydroxypyridine:** 2-Cl → 2-OH via KOH/H₂O, reflux (SNAr on deficient ring); yield 70–80%. Or: directly use 3-formyl-2-hydroxypyridine as starting material if available.
3. **α-Bromo ketone preparation:** 4-(methoxycarbonyl)-2-cyclopentylacetophenone (or phenacyl analog) + NBS, AcOH; yield 80–90%.
4. **Tandem condensation → furopyridine:** aldehyde + α-bromo ketone + K₂CO₃, DMF, 80 °C → furo[2,3-b]pyridine formation in one pot; yield 45–60% (Majumdar-class precedent).
5. **Saponification:** LiOH; ≥95%.

**LLS: 5 steps.**  
**Overall estimated yield:** 0.80 × 0.75 × 0.85 × 0.52 × 0.95 ≈ 25%.  
**Independence:** New C–C and C–O bonds of the furan ring are both formed in Step 4 by a single transformation, completely different disconnection strategy from Routes 1 and 2.

### Route scoring for 7877

| Criterion | Route 1 (double Suzuki) | Route 2 (5-exo-dig) | Route 3 (cyclodehydration) |
|-----------|------------------------|---------------------|---------------------------|
| LLS | 4–5 | 4–5 | 5 |
| Overall yield | ~30% | ~39% | ~25% |
| Independence | Baseline | ✓ Independent C–O + C–C formation | ✓ Independent (one-pot furan) |
| PG burden | Low | Low (methyl ester) | Low (methyl ester) |
| Purification | Moderate | Moderate | Moderate |
| Scale concerns | None | Need to prepare propargyl | Need aryl acetophenone |
| Literature precedent | Strong (Suzuki) | Validated (Lautens) | Validated (Majumdar) |
| Stereocentres | None | None | None |

**Recommendation: Route 2** is preferred. It offers the best overall yield estimate, both furan ring bonds are formed in a single validated Pd/Cu cyclization step, and the cyclopentylbenzoate aryl group is incorporated in the propargyl building block (convergent). Route 1 is a solid fallback; Route 3 is the most exploratory.

---

## Compound 6: B54 — CORRECTED (First successful AiZ run)

**SMILES (canonical, stereo removed for dispatch):** `O=C(Nc1nc(C=Cc2cn(C3CCCCC3)cn2)cs1)c1cccn1Cc1ccncc1`  
**Original SMILES:** `O=C(Nc1nc(/C=C/c2cn(C3CCCCC3)cn2)cs1)c1cccn1Cc1ccncc1`  

**CRITICAL CORRECTION:** The original AiZ dispatch failed with `error="input_file_not_staged"`, `duration_s=0.0`, `image=null`. The SMILES string containing forward slashes (`/C=C/`) was misinterpreted as a file path by the tool dispatch framework. No container was ever started. This was **not** a timeout. The phase-1 text claiming "AiZynthFinder cannot handle B54 within its timeout" was unsupported.

**Corrected AiZ result (dispatch 2026-09-02, rc=0, duration_s=78.9):**  
`is_solved=True`, `n_routes=4`, `n_solved_routes=1`, `top_score=0.963`  
**Source file:** `aizynthfinder-results-6.json`

### Structural features
- 2-Aminothiazole core; C4 bears `(E)-2-(1-cyclohexyl-1H-imidazol-4-yl)vinyl`
- Exocyclic amide N-H to 1-(pyridin-4-ylmethyl)pyrrole-2-carbonyl
- No stereocentres (the E-double bond at C4 is geometric, not a tetrahedral stereocentre)

### Strategic disconnections

| Route | Key disconnection |
|-------|------------------|
| 1 (AiZ, fully solved) | Hantzsch via primary α-bromo enone → aminothiazole; preceded by imidazole methanol oxidation + aldol with acetone; amide coupling |
| 2 | Suzuki vinyl-iodothiazole + imidazole boronate |
| 3 | Horner-Wadsworth-Emmons (HWE) on 4-formylthiazole |

### Route 1 (AiZ-validated, recommended)

**Building blocks (all 5/5 in stock):**
- `OCc1cn(C2CCCCC2)cn1` — (1-cyclohexyl-1H-imidazol-4-yl)methanol (Combi-Blocks, stock)
- `CC(C)=O` — acetone (commodity)
- `O=C1CCC(=O)N1Br` — NBS (commodity)
- `NC(N)=S` — thiourea (commodity)
- `O=C(O)c1cccn1Cc1ccncc1` — 1-(pyridin-4-ylmethyl)-1H-pyrrole-2-carboxylic acid (Enamine, on-demand)

**Forward sequence:**
1. **Alcohol oxidation:** `(1-cyclohexylimidazol-4-yl)methanol` → `(1-cyclohexylimidazol-4-yl)carbaldehyde`; MnO₂ (activated, 5 eq), CH₂Cl₂, RT, 4 h; yield 85–92% (lit. class: benzylic/imidazolylmethanol → aldehyde, MnO₂, Grieco precedent). *Alternatively: Swern, −78 °C, 90%.*
2. **Crossed aldol/Knoevenagel:** imidazole-4-carbaldehyde + acetone (5 eq) → (E)-4-(1-cyclohexyl-1H-imidazol-4-yl)but-3-en-2-one; 10% NaOH aq/EtOH, RT, 2 h; yield 60–70% (lit. class: aromatic aldehyde + acetone aldol condensation, Clayden OC p. 645). *Selectivity: no competing self-condensation of acetone at RT with imidazole aldehyde as the electrophile.*
3. **NBS α-bromination:** enone + NBS (1.1 eq), AcOH/CHCl₃ (1:1), 0 °C → RT; yield 75–85%. Bromination at the CH₃ adjacent to carbonyl (terminal methyl of enone) to give `BrCH₂-CO-CH=CH-imidazoyl`. *Care: avoid allylic bromination; ionic conditions (AcOH) favour α-keto selectivity over radical allylic pathway (radical conditions would give allylic Br).*
4. **Hantzsch thiazole cyclization:** α-bromo enone + thiourea → 2-amino-4-[(E)-2-(1-cyclohexylimidazol-4-yl)vinyl]thiazole; EtOH, reflux, 2 h; yield 70–80%. *Regiochemistry: carbonyl C bearing the vinyl-imidazoyl → C4 of thiazole; CH₂Br (no substituent) → C5. This gives the vinyl group at C4, as required.* Lit. precedent: Isloor et al. Eur. J. Med. Chem. 2009.
5. **Amide coupling:** 2-aminothiazole + 1-(4-picolyl)pyrrole-2-COOH; HATU (1.1 eq), DIPEA (3 eq), DMF, 0 °C → RT, 12 h; yield 65–75%. *Coupling at the exocyclic NH₂ of the aminothiazole, not the ring N.* Lit.: Valeur & Bradley, Chem. Soc. Rev. 2009.

**LLS: 5 steps.**  
**Overall estimated yield:** 0.88 × 0.65 × 0.80 × 0.75 × 0.70 ≈ **24%**  
**Stereochemistry:** E-geometry of the vinyl group is set in Step 2 (thermodynamic E-aldol product under reversible conditions) and confirmed by the AiZ SMILES. Risk: **low**.  
**PG burden:** None.  
**Scale concerns:** Step 3 (NBS bromination of enone) requires careful temperature control. Gram scale feasible.

### Route 2 (Suzuki/vinylation — independent)

**Key disconnection:** C4–C(vinyl) bond of thiazole → vinyl halide + thiazole boronate, or directly via Heck coupling.  
1. 4-Iodo-2-aminothiazole (commercial, Fluorochem) + (E)-2-(1-cyclohexylimidazol-4-yl)vinyl boronate (prepared from aldehyde by Wittig/HWE then borylation) → Pd(PPh₃)₄, K₂CO₃; yield 60–75%.
2. Amide coupling as Route 1 Step 5.
**LLS: 4 steps** (if vinyl boronate is commercially available). **Independent disconnection:** C4–vinyl Pd coupling vs Hantzsch C4 formation.

### Route 3 (HWE on 4-formylthiazole — independent)

**Key disconnection:** C4-CHO thiazole + phosphonate of cyclohexylimidazole → HWE olefination.  
1. 2-Amino-4-formylthiazole (commercial, Sigma-Aldrich) + diethyl(1-cyclohexylimidazol-4-ylmethyl)phosphonate → HWE; NaH, THF, 0 °C → RT; yield 55–70% (E-selective for aryl phosphonates, Still & Gennari conditions for Z if needed).
2. Amide coupling as Route 1 Step 5.
**LLS: 3 steps.** Potentially highest overall yield; depends on phosphonate preparation.

### Route scoring for B54

| Criterion | Route 1 (Hantzsch) | Route 2 (Suzuki) | Route 3 (HWE) |
|-----------|-------------------|-----------------|---------------|
| LLS | 5 | 4 | 3 |
| Overall yield | ~24% | ~30% | ~40% |
| All commercial SM | ✓ | Partial | Partial (phosphonate) |
| Independence | Baseline | ✓ (Pd C–C) | ✓ (olefination) |
| Stereocontrol | E from thermodynamics | E from geometry of SM | E from HWE |
| PG burden | None | None | None |
| Purification | Moderate | Moderate | Easy (one alkene-forming step) |
| Literature precedent | Strong | Strong | Strong |

**Recommendation: Route 1.** All five starting materials are in commercial stock; the AiZ policy fully validated the route; step chemistry is well-precedented. Route 3 is the most efficient in step count and could be attempted in parallel if the phosphonate reagent is prepared.

---

## Compound 7: Mablink (ADC Linker-Payload)

**SMILES:** (MW 1962, antibody-drug conjugate linker-payload; not a small-molecule target)  
**AiZ assessment:** Out of scope for AiZynthFinder (tool covers MW < ~800 drug-like small molecules with ZINC stock set). AiZynthFinder was not run on this compound.

### Programme-level analysis

**Payload:** Exatecan (DXd class, topoisomerase-I inhibitor, MW ≈ 510). Exatecan mesylate is commercially available (Jinsei/Daiichi-Sankyo licensed intermediates) or prepared by total synthesis (hexacyclic camptothecin analogue, >12 steps from 4-quinolone-2-carbaldehyde; Sawada 1991 Chem. Pharm. Bull.).

**Linker:** Polysar/maleimide type. Self-immolative linker: maleimide-PEG-Val-Cit-PAB-carbonate → connects to payload OH. Key steps: SPPS-like solid-phase or solution-phase assembly; dipeptide Val-Cit (commercial, Bachem); PAB-carbonate (4-aminobenzyl activation); maleimide introduction (N-hydroxysuccinimide reagent).

**Conjugation strategy:** Thiol-maleimide (cysteine-selective) via reduced antibody cysteine pairs (interchain disulfides, reduced TCEP). DAR 4 typical.

**Synthetic programme (payload + linker + conjugation):**
1. Exatecan: obtain or synthesize (commercial supply preferred for Phase 1).
2. Linker assembly: Val-Cit PABC spacer + maleimide-PEG activated NHS ester → 5–8 steps, each step ~75–85%; overall ~20–35%.
3. Payload-linker coupling: exatecan OH + PAB-carbonate-Cl or -NHS; DIPEA, DMF; 60–75%.
4. ADC conjugation: thiol-maleimide; 4 °C, phosphate buffer pH 7.2, 12 h; DAR assessed by HIC-HPLC.

**Not applicable for route scoring framework** (ADC programme, not small molecule).

---

## Overall summary

| Compound | AiZ status | Recommended route | LLS | Key reason |
|----------|-----------|------------------|-----|------------|
| MCUF651 | Solved (score 0.994) | Route 1 (amide + N-alkyl) | 2 | All commercial, clean stereocontrol |
| A317 | Solved (score 0.987) | Route 1 (AiZ Hantzsch + amide) | 5 | AiZ-validated, chiral pool pyrrolidine |
| 8008 | Unsolved (score 0.817) | Route 1 (sulfonyl + Sonogashira) | 7 | Only mapped route to missing sulfonyl chloride |
| 7977 | Solved (score 0.963) | Route 1 (CDI + Suzuki) | 4 | All commercial, no stereocentres |
| 7877 | Unsolved (score 0.773) | Route 2 (5-exo-dig, Lautens) | 5 | Best yield, Pd/Cu cyclization validated for furo[2,3-b]pyridine |
| B54 | Solved (score 0.963) | Route 1 (Hantzsch, AiZ-validated) | 5 | All commercial, fully AiZ-solved |
| Mablink | N/A (ADC) | Programme-level only | N/A | Out of AiZ scope |

---

## Audit corrections summary

| Finding | Original error | Correction applied |
|---------|---------------|-------------------|
| CRITICAL-1 (7877) | Ring called oxazolo[4,5-c]pyridine; Routes 2&3 targeted oxazole N-C bond formation | Ring confirmed as furo[2,3-b]pyridine by RDKit; Routes 2&3 replaced with Lautens 5-exo-dig and Majumdar cyclodehydration |
| CRITICAL-2 (B54) | AiZ failure characterised as timeout; stated "AiZ cannot handle B54" | Failure was SMILES-as-filename error (0.0 s, never ran). B54 re-run (rc=0, 78.9 s), is_solved=True, 4 routes, top_score=0.963 |
| CRITICAL-3 (A317) | AiZ Route 1 flagged as Hantzsch regiochemical error; replaced with "corrected" route | AiZ Route 1 is correct. Pyrrolidinyl on carbonyl C → C4 of thiazole ✓. The "correction" proposed alpha-C placement → C5 (wrong). Restored. |
| MAJOR | No persistent document written in phase 1 | This document resolves that. |
